Chronic lymphocytic leukaemia and Infection in an immunocompromised host

Summary:

Infection in an immunocompromised host is found among people with Chronic lymphocytic leukaemia, especially for people who are female, 60+ old.

The study analyzes which people have Infection in an immunocompromised host with Chronic lymphocytic leukaemia. It is created by eHealthMe based on reports of 13 people who have Chronic lymphocytic leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Chronic lymphocytic leukaemia?

Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)) is found to be associated with 382 drugs and 529 conditions by eHealthMe. Check the latest studies of Chronic lymphocytic leukaemia.

What is Infection in an immunocompromised host?

Infection in an immunocompromised host is found to be associated with 87 drugs and 292 conditions by eHealthMe. Check the latest studies of Infection in an immunocompromised host.

On Jul, 19, 2026

13 people who have Chronic Lymphocytic Leukaemia and Infection In An Immunocompromised Host are studied.

Would you have Infection in an immunocompromised host when you have Chronic lymphocytic leukaemia?

Gender of people who have Chronic Lymphocytic Leukaemia and experienced Infection In An Immunocompromised Host *:

female: 54.55 %
male: 45.45 %

Age of people who have Chronic Lymphocytic Leukaemia and experienced Infection In An Immunocompromised Host *:

Common co-existing conditions for these people *:

Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 23.08%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 7.69%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 7.69%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 7.69%

Common drugs taken by these people *:

Common symptoms for these people *:

Fever: 6 people, 46.15%
Bone Pain: 5 people, 38.46%
Fatigue (feeling of tiredness): 5 people, 38.46%
Joint Pain: 4 people, 30.77%
Nosebleed (bleeding from nose): 3 people, 23.08%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 23.08%
Coughing Up Blood: 3 people, 23.08%
Depressed Mood: 3 people, 23.08%
Nasal Dryness (dry nose): 3 people, 23.08%
Skin Infection: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Infection in an immunocompromised host?

- Check whether Infection in an immunocompromised host is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Chronic lymphocytic leukaemia (85,753 reports)
Infection in an immunocompromised host (878 reports)

All the drugs that are associated with Infection in an immunocompromised host:

Infection in an immunocompromised host (87 drugs)

All the conditions that are associated with Infection in an immunocompromised host:

Infection in an immunocompromised host (292 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Infection in an immunocompromised host and Chronic lymphocytic leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.